Umut S et al. |
Determination of the etiological organism during acute exacerbations of COPD and efficacy of azithromycin, ampicillin-sulbactam, ciprofloxacin and cefaclor. Turkish Thoracic Society COPD Working Group. |
1999 |
J Chemother |
pmid:10435684
|
Foulds G et al. |
The effect of azithromycin on the pharmacokinetics of indinavir. |
1999 |
J Clin Pharmacol |
pmid:10434237
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Foster DR and Milan NL |
Potential interaction between azithromycin and warfarin. |
1999 |
Pharmacotherapy |
pmid:10417043
|
Sawhney N |
MAC prophylaxis in the era of polypharmacy. |
1999 May-Jun |
WMJ |
pmid:10414219
|
Neiger R et al. |
Use of a urea breath test to evaluate short-term treatments for cats naturally infected with Helicobacter heilmannii. |
1999 |
Am. J. Vet. Res. |
pmid:10407483
|
Donati M et al. |
Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp. |
1999 |
J. Antimicrob. Chemother. |
pmid:10404322
|
Horgan SE et al. |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection. |
1999 |
J. Med. Microbiol. |
pmid:10403423
|
de Vries PI et al. |
Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. |
1999 |
Trop. Med. Int. Health |
pmid:10402979
|
Taylor KI and Taylor HR |
Distribution of azithromycin for the treatment of trachoma. |
1999 |
Br J Ophthalmol |
pmid:10396186
|
Baće A et al. |
Short-term treatment of pertussis with azithromycin in infants and young children. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10385021
|
Steele-Moore L et al. |
In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10383373
|
Trautmann M et al. |
Combined activity of azithromycin and lansoprazole against Helicobacter pylori. |
1999 |
Helicobacter |
pmid:10382125
|
Lombardo L et al. |
Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and azithromycin: failure of a "promising" association. |
1999 |
Ital J Gastroenterol Hepatol |
pmid:10379493
|
Schönwald S et al. |
Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study. |
1999 May-Jun |
Infection |
pmid:10378132
|
Alvarez-Elcoro S and Enzler MJ |
The macrolides: erythromycin, clarithromycin, and azithromycin. |
1999 |
Mayo Clin. Proc. |
pmid:10377939
|
Dimitrakov J et al. |
A case of Chlamydia trachomatis infection in a renal allograft patient. |
1998 |
Folia Med (Plovdiv) |
pmid:10371799
|
Preheim LC et al. |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia. |
1999 |
Alcohol. Clin. Exp. Res. |
pmid:10371404
|
Johnson JR |
Therapy for Legionnaires disease. |
1999 |
Ann. Intern. Med. |
pmid:10366385
|